Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15957869 | 0.80 | — | — | |
| SCHEMBL20997436 | 0.80 | KDM4E (0.33) | — | |
| SCHEMBL1535703 | 0.79 | PLA2G7 (0.31) | GRM5 | |
| SCHEMBL16168308 | 0.75 | GAA (0.33) | — | |
| SCHEMBL20841198 | 0.74 | — | — | |
| SCHEMBL21205443 | 0.74 | KDM4E (0.32) | — | |
| SCHEMBL23612406 | 0.73 | — | — | |
| SCHEMBL632711 | 0.71 | — | — | |
| SCHEMBL21467021 | 0.71 | BRD4 (0.31) | — | |
| SCHEMBL7951903 | 0.70 | ALDH1A1 (0.36) | PKM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 821 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12638614-B2 | Method for making silicone hydrogel contact lenses | ALCON INC. (CH) | 2026-05-26 | — | — | US | claimed |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-05-14 | — | — | US | claimed |
| US-12595368-B2 | UV/HEVL-filtering contact lenses | ALCON INC. (CH) | 2026-04-07 | — | — | US | claimed |
| EP-4713721-A1 | UV/HEVL-FILTERING SILICONE HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-03-25 | — | — | EP | claimed |
| EP-4707315-A1 | COPOLYMER, COMPOSITION AND USE THEREOF | Beijing Mapu New Materials Co., Ltd. (CN) | 2026-03-11 | — | — | EP | claimed |
| US-12570784-B2 | Method for making embedded hydrogel contact lenses | ALCON INC. (CH) | 2026-03-10 | — | — | US | claimed |
| EP-3759528-B1 | SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-03-04 | — | — | EP | claimed |
| EP-4514596-B1 | METHOD FOR MAKING SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2026-03-04 | — | — | EP | claimed |
| US-12539650-B2 | Method for making embedded hydrogel contact lenses | ALCON INC. (CH) | 2026-02-03 | — | — | US | claimed |
| US-20250347826-A1 | METHOD FOR PRODUCING WETTABLE SILICONE HYDROGEL CONTACT LENSES | ALCON INC (CH) | 2025-11-13 | — | — | US | claimed |
| US-6926965-B2 | LbL-coated medical device and method for making the same | NOVARTIS AG (CH) | 2005-08-09 | — | — | US | claimed |
| EP-1539263-A1 | LBL-COATED MEDICAL DEVICE AND METHOD FOR MAKING THE SAME | Novartis AG (CH) | 2005-06-15 | — | — | EP | claimed |
| US-20040067365-A1 | LbL-coated medical device and method for making the same | ALCON INC. (CH) | 2004-04-08 | — | — | US | claimed |
| WO-2004024203-A1 | LBL-COATED MEDICAL DEVICE AND METHOD FOR MAKING THE SAME | NOVARTIS AG (CH) | 2004-03-25 | — | — | WO | claimed |
| CN-1283280-A | Actively controllable multifocal lens | NOVARTIS AG (CH) | 2001-02-07 | — | — | CN | claimed |
| EP-1044389-A2 | ACTIVELY CONTROLLABLE MULTIFOCAL LENS | Novartis AG (CH) | 2000-10-18 | — | — | EP | claimed |
| US-5997140-A | Actively controllable multifocal lens | NOVARTIS AG (CH) | 1999-12-07 | — | — | US | claimed |
| WO-1999034239-A2 | ACTIVELY CONTROLLABLE MULTIFOCAL LENS | NOVARTIS AG (CH) | 1999-07-08 | — | — | WO | claimed |
| US-4123408-A | Hydrogel contact lens | AMERICAN OPTICAL CORPORATION (US) | 1978-10-31 | — | — | US | claimed |
| US-4123407-A | Hydrophilic contact lens | AMERICAN OPTICAL CORPORATION (US) | 1978-10-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12539650-B2 | Method for making embedded hydrogel contact lenses | INF2, CRYZ, CRYAA | GRM5 4205/4885PKM 3590/4885 |
| US-12595368-B2 | UV/HEVL-filtering contact lenses | UACA, HSPA4L, RAD54L | GRM5 2926/4885PKM 2225/4885 |
| US-12570784-B2 | Method for making embedded hydrogel contact lenses | CRYAB, CRYZ, CRYAA | GRM5 4056/4885PKM 2661/4885 |
| US-12638614-B2 | Method for making silicone hydrogel contact lenses | SMCHD1, CRYAA, CRYZ | GRM5 838/4885PKM 2917/4885 |
| US-20260131506-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | CRYZ, CRYAB, CRYAA | GRM5 3693/4885PKM 2895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.